About the Webinar

This webinar will explore how 3D genomics can enhance diagnostic accuracy and uncover novel therapeutic targets in uterine sarcoma. Participants will gain insights into the advantages of 3D genomic approaches compared to traditional clinical next-generation sequencing (NGS) assays. Attendees will also learn about the implications of these advanced genomic techniques for clinical practice and patient care in gynecologic oncology.

 

Meet the Speakers:

Sarah Chiang, MD

Pathologist at Memorial Sloan Kettering Cancer Center

Sarah is a board-certified surgical pathologist with clinical expertise in gynecologic pathology. In addition to her clinical responsibilities, she maintains an active commitment to translational research in the diagnosis and pathogenesis of uterine sarcomas.

Anthony Schmitt, PhD

SVP of Science, Aventa Genomics

Anthony Schmitt, PhD, is the SVP of Science at Aventa Genomics, where his expertise in 3D genomics has been pivotal to the company's development of Hi-C technology and its applications in genomics research. He received his PhD from the University of California, San Diego, where he developed novel methodologies for understanding gene regulation using 3D genomics approaches. Since Aventa's inception, Anthony has led the development of the core Aventa Hi-C chemistry and technology platform, as well as industry partnerships and academic collaborations.